HB 2710

  • Washington House Bill
  • 2019-2020 Regular Session
  • Introduced in House
  • House
  • Senate
  • Governor

Modifying the uses, disclosure, and requirement dates of prescription drug price transparency data.

Votes


Actions


Mar 12, 2020

House

By resolution, returned to House Rules Committee for third reading.

Feb 28, 2020

Senate

Scheduled for public hearing in the Senate Committee on Health & Long Term Care at 08:00 AM

Feb 19, 2020

House

First reading, referred to Health & Long Term Care.

Feb 17, 2020

House

Third reading, passed; yeas, 56; nays, 42; absent, 0; excused, 0.

House

Rules suspended. Placed on Third Reading.

Feb 16, 2020

House

Rules Committee relieved of further consideration. Placed on second reading.

Feb 06, 2020

House

Referred to Rules 2 Review.

Feb 04, 2020

House

Scheduled for public hearing in the House Committee on Health Care & Wellness at 01:30 PM

Feb 04, 2020

House

HCW - Majority; do pass.

Jan 29, 2020

House

Scheduled for public hearing in the House Committee on Health Care & Wellness at 01:30 PM

Jan 20, 2020

House

First reading, referred to Health Care & Wellness.

Bill Text

Bill Text Versions Format
Bill HTML

Related Documents

Document Format
Report HTML HTML HTML
Amendment SHMK WEIK 164 HTML

Sources

Data on Open States is updated periodically throughout the day from the official website of the Washington State Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.